List of Excipients in API prazosin hcl
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing prazosin hcl
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 | CELLULOSE, MICROCRYSTALLINE |
| Direct_Rx | prazosin hcl | 72189-436 | FERROSOFERRIC OXIDE |
| Direct_Rx | prazosin hcl | 72189-436 | GELATIN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for prazosin hcl
Excipient focus: CELLULOSE, MICROCRYSTALLINE
prazosin hcl drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
prazosin hcl drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
prazosin hcl drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
prazosin hcl drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
prazosin hcl drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
prazosin hcl drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
prazosin hcl drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
prazosin hcl drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
prazosin hcl drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
prazosin hcl drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
prazosin hcl drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
prazosin hcl drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
prazosin hcl drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | prazosin hcl | 72189-436 |
| Direct_Rx | prazosin hcl | 72189-470 |
| Direct_Rx | prazosin hcl | 72189-540 |
| >Company | >Ingredient | >NDC |
prazosin hcl drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch